Sofie Biosciences Closes $5M in Series A Financing

Sofie Biosciences, a Culver City-based diagnostics company, raised $5m in a Series A financing.

The round was led by Tata Industries with participation from existing investors MRM Capital and the Cycad Group.

The company intends to use the funds to further develop its technologies.

Founded in 2008 and led by President & CEO Patrick Phelps, Sofie Biosciences provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. Its technologies focus on increasing the availability of Positron Emission Tomography (PET) imaging and its application base. One of the most promising developments is a self-shielded microfluidic chip-based synthesizer for on-demand PET probe production.
The company is a spinout of UCLA and Caltech.

FinSMEs

16/10/2013

Join the discussion